Of note, therapeutic overexpression of the human H19 homolog (instead of murine H19) was similarly effective in blocking cardiac hypertrophy of TAC-operated mice, highlighting again the strong translational potential of H19 in the heart. This evidence concerns the gene H19 and cardiac hypertrophy.